Patents Assigned to Matrix Pharmaceuticals
  • TGF-.beta. protein compositions for inhibition of cell proliferation
    Patent number: 5597578
    Abstract: Antiproliferative compositions are provided which are capable of sustained release of an antiproliferative agent, particularly a TGF-.beta., at a site proximal to a target cell. The compositions are effective in inhibiting proliferation of the target cell, particularly when used in combination with a vasoconstrictive agent.
    Type: Grant
    Filed: April 28, 1994
    Date of Patent: January 28, 1997
    Assignees: Oncogen, Matrix Pharmaceuticals
    Inventors: Dennis M. Brown, Edward Luck, Daniel R. Twardzik, Anthony F. Purchio